ALOGLIPTIN\PIOGLITAZONE: 331 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
331
Total FAERS Reports
12 (3.6%)
Deaths Reported
96
Hospitalizations
331
As Primary/Secondary Suspect
15
Life-Threatening
6
Disabilities
Active Ingredient: ALOGLIPTIN BENZOATE\PIOGLITAZONE HYDROCHLORIDE ·
First Report: 200803 · Latest Report: 20250527
What Are the Most Common ALOGLIPTIN\PIOGLITAZONE Side Effects?
#1 Most Reported
Weight increased
21 reports (6.3%)
#2 Most Reported
Pancreatitis
11 reports (3.3%)
#3 Most Reported
Rash
10 reports (3.0%)
All ALOGLIPTIN\PIOGLITAZONE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Weight increased | 21 | 6.3% | 0 | 1 |
| Pancreatitis | 11 | 3.3% | 0 | 8 |
| Blood glucose increased | 10 | 3.0% | 0 | 1 |
| Pemphigoid | 10 | 3.0% | 0 | 6 |
| Rash | 10 | 3.0% | 0 | 1 |
| Bladder cancer | 9 | 2.7% | 0 | 3 |
| Oedema | 9 | 2.7% | 0 | 2 |
| Vision blurred | 9 | 2.7% | 0 | 0 |
| Cardiac failure | 8 | 2.4% | 0 | 5 |
| Drug ineffective | 8 | 2.4% | 0 | 0 |
| Pancreatitis acute | 8 | 2.4% | 0 | 4 |
| Headache | 7 | 2.1% | 0 | 0 |
| Hypoglycaemia | 7 | 2.1% | 0 | 5 |
| Interstitial lung disease | 7 | 2.1% | 1 | 2 |
| Nausea | 7 | 2.1% | 0 | 1 |
| Abdominal pain upper | 6 | 1.8% | 0 | 1 |
| Cardiac disorder | 6 | 1.8% | 1 | 2 |
| Haematuria | 6 | 1.8% | 0 | 1 |
| Malaise | 6 | 1.8% | 1 | 2 |
| Myalgia | 6 | 1.8% | 0 | 0 |
Who Reports ALOGLIPTIN\PIOGLITAZONE Side Effects? Age & Gender Data
Gender: 49.3% female, 50.7% male. Average age: 68.8 years. Most reports from: US. View detailed demographics →
Is ALOGLIPTIN\PIOGLITAZONE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2008 | 1 | 0 | 0 |
| 2012 | 4 | 3 | 0 |
| 2013 | 16 | 1 | 3 |
| 2014 | 32 | 1 | 13 |
| 2015 | 26 | 1 | 8 |
| 2016 | 26 | 1 | 17 |
| 2017 | 14 | 0 | 6 |
| 2018 | 12 | 1 | 6 |
| 2019 | 8 | 0 | 3 |
| 2020 | 1 | 0 | 0 |
| 2021 | 1 | 0 | 0 |
| 2022 | 2 | 0 | 2 |
| 2023 | 2 | 0 | 1 |
| 2024 | 2 | 0 | 0 |
| 2025 | 2 | 0 | 0 |
What Is ALOGLIPTIN\PIOGLITAZONE Used For?
| Indication | Reports |
|---|---|
| Type 2 diabetes mellitus | 136 |
| Diabetes mellitus | 94 |
| Product used for unknown indication | 76 |
ALOGLIPTIN\PIOGLITAZONE vs Alternatives: Which Is Safer?
ALOGLIPTIN\PIOGLITAZONE vs ALOSETRON
ALOGLIPTIN\PIOGLITAZONE vs ALPELISIB
ALOGLIPTIN\PIOGLITAZONE vs ALPHA.-LIPOIC ACID
ALOGLIPTIN\PIOGLITAZONE vs ALPHA.-TOCOPHEROL
ALOGLIPTIN\PIOGLITAZONE vs ALPHA.-TOCOPHEROL, D-
ALOGLIPTIN\PIOGLITAZONE vs ALPHA.-TOCOPHEROL, DL-
ALOGLIPTIN\PIOGLITAZONE vs ALPHA.1-PROTEINASE INHIBITOR HUMAN
ALOGLIPTIN\PIOGLITAZONE vs ALPRAZOLAM
ALOGLIPTIN\PIOGLITAZONE vs ALPROSTADIL
ALOGLIPTIN\PIOGLITAZONE vs ALTEPLASE
Official FDA Label for ALOGLIPTIN\PIOGLITAZONE
Official prescribing information from the FDA-approved drug label.